ASTEC718.10

Astec LifeSciences Limited

· Chemicals
₹ CrorePeersPUNJABCHEMMOLIPLINSECTICIDDHARMAJBHARATRASADVANCEHERANBAMcap ₹1,600 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation36.343.744.9
+ Finance Costs25.236.734.5
+ Interest Income-0.2-0.8-0.5
+ Share-based Payments0.30.00.1
+ Unrealised FX (Gain) / Loss-0.13.2-2.2
+ Other Non-cash Items0.118.20.0
+ Other — Cash Effects are Investing / Financing0.10.00.1
+ Other Reconciling Items0.00.01.9
Changes in Working Capital
+ Inventories98.915.920.6
+ Trade Receivables — Current-13.518.9-92.1
+ Other Financial Assets — Current0.21.7-0.3
+ Other Financial Assets — Non-current0.00.00.0
+ Other Current Assets15.5-1.3-13.6
+ Other Non-current Assets-0.00.20.2
+ Other Bank Balances-0.00.00.0
+ Trade Payables — Current-88.8-7.84.3
+ Other Financial Liabilities — Current0.10.50.6
+ Other Financial Liabilities — Non-current0.7-1.8-0.3
+ Other Current Liabilities-2.30.4-0.4
+ Provisions — Current1.6-0.22.1
+ Provisions — Non-current0.00.00.9
Cash from Operating Activities
Profit Before Tax (per I/S)-61.7-141.0-81.0-66.7
+ Total Adjustments (incl. Working Capital)73.9127.60.9
Cash from Operations (pre-tax)12.2-13.4-80.1
+ Income Taxes Paid2.0-5.00.6
Cash from Operating Activities10.2-8.4-80.7
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)135.521.85.5
+ Disp of Fixed Assets0.46.00.7
+ Interest Received — Investing0.20.80.6
+ Other Inflows / (Outflows) — Investing-0.3-0.2-0.1
Cash from Investing Activities-135.2-15.2-4.3
Cash from Financing Activities
+ Proceeds from Issue of Shares0.10.0236.2
+ Proceeds from Borrowings199.0171.00.0
+ Repayment of Borrowings48.0108.7109.1
+ Interest Paid23.238.632.6
+ Dividends Paid2.90.00.0
Cash from Financing Activities125.023.794.5
Net Changes in Cash (pre-FX)-0.00.19.5
Net Changes in Cash-0.00.19.5
Closing Cash0.5
Reference Items
EBITDA-5.9-66.2-4.55.8
EBITDA Margin %-1.29-17.36-1.011.31
Free Cash Flow (CFO − Capex)-125.3-30.2-86.2-86.2
Free Cash Flow to Equity-8.1-224.4
Free Cash Flow per Basic Share-56.22-13.56-38.71-38.71
Cash Flow to Net Income-0.220.061.00
Cash Paid for Taxes2.0-5.00.6
Cash Paid for Interest23.238.632.6
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.